Valuation: Micropos Medical AB

Market Cap 303M 30.21M 26.86M 25.04M 22.82M 43.08M 2.91B 43.46M 118M 1.48B 113M 111M 4.81B P/E 2024
-11.7x
P/E 2025 -12.6x
Enterprise Value 294M 29.23M 25.99M 24.22M 22.08M 41.68M 2.82B 42.05M 114M 1.44B 110M 107M 4.65B EV / Sales 2024
63.4x
EV / Sales 2025 32.4x
Free-Float
60.96%
Yield 2024 *
-
Yield 2025 -
3 years 1.26
Extreme 1.255
3.51
5 years 1.26
Extreme 1.255
3.73
10 years 0.58
Extreme 0.58
3.99
Manager TitleAgeSince
Chief Executive Officer 60 2020-05-31
Chief Tech/Sci/R&D Officer - 2020-10-31
Chief Tech/Sci/R&D Officer 46 2016-07-31
Director TitleAgeSince
Director/Board Member 64 2011-12-31
Chairman 86 2018-12-31
Director/Board Member 47 2022-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%-.--%-.--%-20.77% 30.23M
+0.35%-2.99%+24.73%+32.07% 242B
+1.09%-4.65%+1.77%+0.15% 150B
-2.32%-3.27%-11.53%+32.87% 138B
-1.46%-3.01%-55.73%-19.33% 61.74B
-0.05%-1.32%+11.09%+23.08% 49.08B
+0.66%+0.19%-19.29%-21.24% 47.43B
+0.66%-2.90%+20.97%+51.29% 47.3B
-3.05%-2.62%-9.13%+35.86% 44.25B
-0.08%-1.92%+32.09%+57.18% 41.78B
Average -0.72%-2.25%-0.50%+17.12% 82.27B
Weighted average by Cap. -0.29%-3.27%+3.37%+21.48%

Financials

2024 2025
Net sales 3.82M 381K 339K 316K 288K 543K 36.67M 548K 1.48M 18.71M 1.43M 1.4M 60.59M 8.13M 809K 719K 671K 611K 1.15M 77.92M 1.16M 3.15M 39.75M 3.04M 2.97M 129M
Net income -21.87M -2.18M -1.94M -1.8M -1.64M -3.11M -210M -3.13M -8.48M -107M -8.18M -8M -346M -21.7M -2.16M -1.92M -1.79M -1.63M -3.08M -208M -3.11M -8.42M -106M -8.11M -7.94M -344M
Net Debt -7.71M -768K -683K -636K -580K -1.09M -73.94M -1.1M -2.99M -37.72M -2.88M -2.82M -122M -9.84M -980K -871K -812K -740K -1.4M -94.37M -1.41M -3.82M -48.15M -3.68M -3.6M -156M
Logo Micropos Medical AB
Micropos Medical AB (publ) is a Sweden-based company engaged in the development of medical devices for high precision four dimensional (4D) radiotherapy. The Company’s product is RayPilot, an electromagnetic positioning system that enables real time information of the position of the prostate. The system works as an add-on to existing linear accelerators and enables control of a region of interest (ROI) position throughout every radiotherapy session. It consists of RayPilot receiving system, RayPilot transmitter that is placed in the ROI, and RayPilot software. The Company markets its products through sales offices in the Nordic countries, a network of distributors in Europe, the United States and Asia, and through Business to Business (B2B) partnerships with T ex Elekta and Varian & Siemens.
Employees
12
  1. Stock Market
  2. Stocks
  3. MPOS Stock